CRISPR Therapeutics AG (NASDAQ:CRSP)

66.52
Delayed Data
As of Jun 24
 +1.37 / +2.10%
Today’s Change
42.51
Today|||52-Week Range
169.76
-12.22%
Year-to-Date
Should You Sell Biotech Stocks If There's a Recession?
Jun 23 / MotleyFool.com - Paid Partner Content
3 Bargain Stocks You Can Buy Today and Hold Forever
Jun 17 / MotleyFool.com - Paid Partner Content
CRISPR Therapeutics AG (CRSP) Moves 8.3% Higher: Will This Strength Last?
Jun 20 / Zacks.com - Paid Partner Content
2 Top Biotech Stocks Ready for Bull Runs
Jun 15 / MotleyFool.com - Paid Partner Content
Why Bluebird Bio Skyrocketed Today
Jun 17 / MotleyFool.com - Paid Partner Content
2 Hot Stocks to Buy and Hold Until You Retire
Jun 12 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close65.15
Today’s open66.57
Day’s range61.04 - 67.14
Volume231,800
Average volume (3 months)1,693,434
Market cap$5.4B
Data as of 4:05pm ET, 06/24/2022

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-290.67%
Earnings growth (next 5 years)-10.83%
Revenue growth (last year)+127,154.94%
P/E ratio17.1
Price/Sales6.66
Price/Book2.25

Competitors

----
----
----
NTLAIntellia Therapeutic...+2.68+5.28%
Data as of 4:00pm ET, 06/24/2022

Financials

Next reporting dateAugust 10, 2022
EPS forecast (this quarter)-$2.22
Annual revenue (last year)$915.0M
Annual profit (last year)$377.7M
Net profit margin41.28%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Zug, Zug

Forecasts